ÊTRE AU SERVICE DES PERSONNES VIVANT AVEC LE DIABÈTE-LA POSITION DE DIABÈTE QUÉBEC (DQ-001)

Thursday, October 26, 2023

08:15 – 09:00 EST

Location: Palais, 518ABC

Modératrice(s)

Claudia Gagnon, MD, FRCPC

Endocrinologue
CHU de Québec-Université Laval
Department of Medicine, Université Laval

Conférencière(s)

Nathalie Chartier (she/her/hers)

Personne vivant avec le diabète et membre du comité consultatif
Diabète Québec

Conférencier(s)

Mario La Rochelle (he/him/his)

Personne vivant avec le diabète et membre du comité consultatif
Diabète Québec
Cégep de St-Jean-sur-Richelieu

Conférencière(s)

SL

Sylvie Lauzon

Présidente-directrice générale
Diabète Québec

Conférencier(s)

Remi Rabasa-Lhoret, MD, PhD (he/him/his)

Endocrinologue
IRCM

Conférencière(s)

VS

Valérie Savard

Nutritionniste
Diabète Québec
Julie St-Jean (she/her/hers)

Nutritionniste
Diabète Québec

PDF

Disclosure(s):

Claudia Gagnon, MD, FRCPC: Amolyt Pharma: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Ascendis Pharma: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novo Nordisk: Consultant/Advisory Board (Terminated); Shire Pharmaceuticals (now Takeda): Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated)

Nathalie Chartier: No financial relationships to disclose

Mario La Rochelle: No financial relationships to disclose

Remi Rabasa-Lhoret, MD, PhD: Cystic Fibrosis Canada: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); FFRD: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Janssen: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); JDRF: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Novo Nordik: Consultant/Advisory Board (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing); Sanofi-Avantis: Consultant/Advisory Board (Terminated), Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated), Speaker/Honoraria (Terminated); Société Francophone du Diabète: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (Ongoing)

Julie St-Jean: Gilead: Employment (Ongoing)

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

brève présentation de Diabète Québec;
démontrer l’importance de travailler de concert avec les personnes vivant avec le diabète;
se familiariser avec les ressources pour les professionnels et les personnes vivant avec le diabète; et
présenter des exemples d’avancées et de retombées directes pour les personnes vivant avec le diabète émergeant de Diabète Québec.